HDAC9 and lymphoma: For example, HDAC inhibitor, VPA, could induce EBV lytic cycle in EBV-associated epithelial carcinomas such as C666-1 and AGS-EBV cells [48], but not in EBV-positive lymphomas such as HH514-16, Raji, and Akata cells [49,50].